Unknown

Dataset Information

0

Triple Vectors Expand AAV Transfer Capacity in the Retina.


ABSTRACT: Retinal gene transfer with adeno-associated viral (AAV) vectors holds great promise for the treatment of inherited retinal degenerations (IRDs). One limit of AAV is its transfer capacity of about 5 kb, which can be expanded to about 9 kb, using dual AAV vectors. This strategy would still not suffice for treatment of IRDs such as Usher syndrome type 1D or Alström syndrome type I (ALMS) due to mutations in CDH23 or ALMS1, respectively. To overcome this limitation, we generated triple AAV vectors, with a maximal transfer capacity of about 14 kb. Transcriptomic analysis following triple AAV transduction showed the expected full-length products along a number of aberrant transcripts. However, only the full-length transcripts are efficiently translated in vivo. We additionally showed that approximately 4% of mouse photoreceptors are transduced by triple AAV vectors and showed correct localization of recombinant ALMS1. The low-photoreceptor transduction levels might justify the modest and transient improvement we observe in the retina of a mouse model of ALMS. However, the levels of transduction mediated by triple AAV vectors in pig retina reached 40% of those observed with single vectors, and this bodes well for further improving the efficiency of triple AAV vectors in the retina.

SUBMITTER: Maddalena A 

PROVIDER: S-EPMC5835116 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Triple Vectors Expand AAV Transfer Capacity in the Retina.

Maddalena Andrea A   Tornabene Patrizia P   Tiberi Paola P   Minopoli Renato R   Manfredi Anna A   Mutarelli Margherita M   Rossi Settimio S   Simonelli Francesca F   Naggert Jurgen K JK   Cacchiarelli Davide D   Auricchio Alberto A  

Molecular therapy : the journal of the American Society of Gene Therapy 20171205 2


Retinal gene transfer with adeno-associated viral (AAV) vectors holds great promise for the treatment of inherited retinal degenerations (IRDs). One limit of AAV is its transfer capacity of about 5 kb, which can be expanded to about 9 kb, using dual AAV vectors. This strategy would still not suffice for treatment of IRDs such as Usher syndrome type 1D or Alström syndrome type I (ALMS) due to mutations in CDH23 or ALMS1, respectively. To overcome this limitation, we generated triple AAV vectors,  ...[more]

Similar Datasets

2017-12-20 | GSE107173 | GEO
| PRJNA419212 | ENA
| S-EPMC3927955 | biostudies-literature
| S-EPMC2835095 | biostudies-literature
| S-EPMC4700115 | biostudies-literature
| S-EPMC3182350 | biostudies-other
| S-EPMC6730636 | biostudies-literature
| S-EPMC5511854 | biostudies-literature
| S-EPMC5728288 | biostudies-literature